article thumbnail

Pfizer investigational gene therapy for DMD fails in Phase 3 study

Express Pharma

The overall safety profile of fordadistrogene movaparvovec in the CIFFREO trial was manageable, with mostly mild to moderate adverse events, and treatment-related serious adverse events generally responding to clinical management.

article thumbnail

Informa Connect's Rare Disease Innovation & Partnering Summit

Drug Channels

Hybrid Event May 17-19, 2022 | Boston, MA www.informaconnect.com/rare. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net). Rare Disease Innovation & Partnering Summit. Don’t miss the Rare Disease Innovation & Partnering Summit, coming up May 17-19, 2022 in Boston, MA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

How to Improve Communication between Patient and Doctor?

Viseven

Did you know that communicative errors are a major contributing factor to hospital sentinel events? In this method, clinical personnel interacts with caregivers formally. The goal is to learn and write down up to five significant non-clinical management techniques and ideas for individualized care.

article thumbnail

Contents

RX Note

G6PD Deficiency - Explaining G6PD Deficiency Ramadan - Medications during Ramadan fasting Adverse Drug Reactions Adverse Drug Reactions - All adverse reactions are adverse drug event Pharmacovigilance - To detect unreported ADRs Drug Allergy - Management vary based on the signs and symptoms Medicine-induced Discolouration - Red?